SEC Comment Letter 0000000000-24-012947 to TRINITY BIOTECH PLC (TRIB)
TRINITY BIOTECH PLC
Date: Nov. 21, 2024 · CIK: 0000888721 · Accession: 0000000000-24-012947
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283273
Letter
November 21, 2024 John Gillard Chief Executive Officer Trinity Biotech plc IDA Business Park Bray, County Wicklow Ireland Re:Trinity Biotech plc Registration Statement on Form F-3 Filed November 15, 2024 File No. 333-283273 Dear John Gillard: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Mary Brown, Esq.
Show Raw Text
November 21, 2024
John Gillard
Chief Executive Officer
Trinity Biotech plc
IDA Business Park
Bray, County Wicklow
Ireland
Re:Trinity Biotech plc
Registration Statement on Form F-3
Filed November 15, 2024
File No. 333-283273
Dear John Gillard:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Mary Brown, Esq.